Clinical Trial Update: A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and efficacy of adding Anacetrapib to ongoing statin therapy in Japanese participants with dyslipidemia; the trial has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Anacetrapib (anacetrapib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Dyslipidemia | Phase 3 | Status: COMPLETED